Last reviewed · How we verify

NCT06724146

Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance

Active, enrolled NA Last updated 9 December 2024
What this trial tests

NA trial testing Sofwave and Pure Impact in Skin Lax and Muscle Strength in 70 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 August 2024
Primary endpoint
1 October 2026
1 November 2026

Quick facts

Lead sponsorSofwave Medical LTD
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment70
Start date5 August 2024
Primary completion1 October 2026
Estimated completion1 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sofwave Medical LTD

Who can join

Adults 25 to 70, any sex, with Skin Lax and Muscle Strength. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sofwave Medical LTD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06724146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing